Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2009, for Innovative Acquisitions Corp. (noted as PUMA BIOTECHNOLOGY, INC. in metadata, but identified as Innovative Acquisitions Corp. in the filing text). The registrant is a Delaware corporation classified as a shell company and a smaller reporting company. It operates as a "blank check" company with no specific business plan other than to pursue a business combination through the acquisition of, or merger with, an operating business. The company has generated no revenue since its inception on April 27, 2007.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 | Cumulative (Inception to Mar 31, 2009) |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Net Loss | $(6,007) | $(4,491) | $(35,183) |
| Cash Balance (End of Period) | $67 | $2,166 | $67 |
| Total Assets | $67 | $2,166 | $67 |
| Total Liabilities | $500 | $2,249 (Dec 31, 2008) | $500 |
| Stockholders' Deficit | $(433) | $(2,176) (Dec 31, 2008) | $(433) |
| Net Cash Used in Operating Activities | $(7,756) | $(4,491) | $(34,683) |
| Net Cash Provided by Financing Activities | $7,750 | $5,250 | $34,750 |
Note: The company has no debt other than accounts payable. Margins are not applicable due to zero revenue.
Material Changes vs. Prior Period
- Net Loss Increase: Net loss for the three months ended March 31, 2009, increased to $6,007 from $4,491 in the same period in 2008. This increase is attributed to higher legal, accounting, and audit fees associated with filing the Annual Report on Form 10-K for the year ended December 31, 2008.
- Liquidity Decline: Cash on hand decreased from $73 at December 31, 2008, to $67 at March 31, 2009. The net decrease in cash for the quarter was $6.
- Liability Reduction: Accounts payable decreased significantly from $2,249 at December 31, 2008, to $500 at March 31, 2009, reflecting a reduction in outstanding obligations.
- Capital Contributions: The company received $7,750 in capital contributions from existing stockholders during the quarter, recorded as additional paid-in capital, with no new shares issued.
Outlook, Risks, and Management Commentary
- Going Concern: The filing explicitly states that the company's continuation as a going concern is dependent upon financial support from shareholders and the ability to obtain necessary equity financing. There is substantial doubt regarding the company's ability to continue as a going concern without additional funding.
- Business Plan: The company has no active operations other than seeking a business combination. It anticipates incurring costs for filing Exchange Act reports and investigating potential acquisitions over the next 12 months.
- Funding Strategy: Management intends to meet future costs through treasury funds, deferral of fees, and additional loans or investments from stockholders and management. There is no assurance that such funding will be available.
- Risks: Risks include the inability to find a suitable acquisition target, the potential instability of target companies, and the general economic conditions affecting capital availability. The company is a "shell company" with nominal assets and operations.
- Unusual Items: The company is a development-stage entity with no revenue. All expenses are related to organizational efforts and regulatory compliance.
Key Facts for Investor Verification
- Critical Liquidity Position: Verify the company's ability to fund operations with only $67 in cash and $500 in liabilities.
- Capital Dependency: Confirm the status of the $7,750 capital contribution and whether further funding from directors/shareholders is secured.
- Going Concern Status: Assess the likelihood of the company obtaining the necessary financing to continue operations beyond the next 12 months.
- Acquisition Progress: Determine if any specific acquisition targets have been identified or if discussions are ongoing, as the company has no revenue-generating operations.
- Share Structure: Note that 3,000,000 shares of common stock are outstanding, and no new shares were issued in Q1 2009 despite capital contributions.